Diabetes Education

Top Story

For type 2 diabetes, intermittent vs. continuous energy restriction yields similar glycemic improvements

For type 2 diabetes, intermittent vs. continuous energy restriction yields similar glycemic improvements
July 20, 2018
FDA News

Dulaglutide label to reflect new safety, efficacy data in type 2 diabetes, CKD

July 20, 2018
Eli Lilly has updated the label for the once-weekly GLP-1 receptor agonist dulaglutide to reflect new safety and efficacy data reported for adults with type 2 diabetes…
In the Journals Plus

Diabetes increases risk for all cancers by 10%

July 20, 2018
Adults with diabetes have a 10% greater risk for developing any cancer vs. those without diabetes, whereas the disease confers a greater risk for overall and certain…

CREDENCE trial stopped early for favorable CKD findings with canagliflozin

July 19, 2018
The steering committee behind the phase 3 CREDENCE clinical trial, evaluating the efficacy and safety of the SGLT2 inhibitor canagliflozin vs. placebo for adults with…
More Headlines »
CME

Early Treatment of Diabetic Retinopathy and Diabetic Macular Edema: Optimal Use of Anti-VEGF Therapy for Vision Preservation and Restoration

This activity is supported by an educational grant from Genentech, Inc.

Diabetic retinopathy (DR) and diabetic macular edema (DME) are 2 of the most common causes of blindness among…
More »
Video
Meeting News

VIDEO: Diabetes language matters

August 5, 2017
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

CME

Advances in Insulin Formulations: What Can They Do for Your Patients with T2DM? - Assessing Patient and Provider Barriers to Injectable Therapies

This activity is supported by an educational grant from Novo Nordisk Inc.

Type 2 diabetes accounts for 90% of the 150 million cases of diabetes worldwide. Education to providers about…
More »